Have a Question? 800.941.6884 · info@epigendx.com

KRAS Assay

KRAS(G12C) Assay

KRAS Mutation Diagram

KRAS Mutation Genetic Testing

The KRAS Gene Mutation Analysis Test is a genetic test that detects KRAS gene abnormalities as well as to test and profile KRAS(G12C) antagonists/inhibitors by monitoring GDP or GTP binding status using BODIPY-GDP. It aids in the identification of appropriate therapeutic medications, such as tyrosine kinase inhibitors (TKIs), and disqualifies certain pharmaceuticals from being employed in cancer treatment.

For additional flexibility, the kit can be used with one of two protocols: titrating the inhibitor with a set GTP concentration or titrating the GTP with a fixed inhibitor concentration.

Target-Specific Assay

Description: KRAS proto-oncogene, GTPase [Source:HGNC Symbol;Acc:HGNC:6407]

Gene Synonyms: KRAS1, KRAS2

Location: Chromosome 12: 25,205,246-25,250,936 reverse strand. GRCh38:CM000674.2

About this gene: This gene has 4 transcripts (splice variants), 200 orthologues, 35 paralogues and is associated with 310 phenotypes.

KRAS table diagram

EpigenDx is committed to quality service in every aspect of our relationships with clients.

Inquire Now
EpigenDx Offers Many Customized Services
YOU DON'T WANT TO MISS THIS!Epigenetics In The A.M. 2021 Event
Are you interested in DNA methylation, gene expression & gene regulation? Then this online event is for you! Let’s share our expertise on how to generate meaningful methylation data for publications, clinical research, biomarker discoveries & much more.

Two lucky winners will win the Raffle Giveaways!